Analyst Price Targets — MD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 12:59 pm | — | UBS | $22.00 | $19.20 | TheFly | Pediatrix Medical price target lowered to $22 from $23 at UBS |
| February 20, 2026 1:32 pm | — | Deutsche Bank | $19.00 | $18.80 | TheFly | Pediatrix Medical price target lowered to $19 from $21 at Deutsche Bank |
| February 19, 2026 6:04 pm | — | Truist Financial | $21.00 | $18.41 | TheFly | Pediatrix Medical price target lowered to $21 from $24 at Truist |
| November 10, 2025 3:04 pm | David MacDonald | Truist Financial | $24.00 | $22.30 | TheFly | Pediatrix Medical price target raised to $24 from $17 at Truist |
| November 5, 2025 2:27 pm | — | UBS | $23.00 | $21.46 | TheFly | Pediatrix Medical price target raised to $23 from $16.50 at UBS |
| October 14, 2025 1:22 pm | David MacDonald | Truist Financial | $17.00 | $16.04 | TheFly | Pediatrix Medical price target raised to $17 from $16 at Truist |
| October 7, 2024 7:11 am | David MacDonald | Truist Financial | $13.00 | $12.13 | TheFly | Pediatrix Medical price target raised to $13 from $10 at Truist |
| September 26, 2024 6:19 am | Jack Slevin | Jefferies | $14.00 | $11.26 | StreetInsider | Jefferies Upgrades Pediatrix Medical Group (MD) to Buy |
| August 15, 2024 8:17 am | David MacDonald | Truist Financial | $10.00 | $10.16 | StreetInsider | Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities |
| June 7, 2024 7:21 am | Pito Chickering | Deutsche Bank | $8.00 | $6.89 | StreetInsider | Deutsche Bank Upgrades Pediatrix Medical Group (MD) to Hold |
Latest News for MD
Ritholtz Wealth Management acquired a new position in Pediatrix Medical Group, Inc. (NYSE: MD) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 101,115 shares of the company's stock, valued at approximately $2,163,000. Ritholtz Wealth Management owned about 0.12% of
SG Americas Securities LLC reduced its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 41.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,060 shares of the company's stock after selling 51,082 shares during the period. SG
Pediatrix Medical Group, Inc. (NYSE: MD - Get Free Report) has earned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.